NYSE:RDWAerospace & Defense
What Redwire (RDW)'s NASA Space Station Biotech Contract Could Mean for Shareholders
On August 28, 2025, Redwire Corporation announced it was awarded a NASA indefinite-delivery/indefinite-quantity contract with a US$25 million ceiling over five years to provide biotechnology facilities, on-orbit operational support, and mission integration for the International Space Station, including an initial US$2.5 million task order for drug development with its PIL-BOX technology.
This milestone highlights both NASA’s recognition of Redwire’s space biotechnology capabilities and the...